Difference between revisions of "Team:TrinityCollegeDublin"
| Line 247: | Line 247: | ||
<div class="container fadeIn"> | <div class="container fadeIn"> | ||
| − | <div class="leftContainer" | + | <div class="leftContainer"><br> |
One of the deadliest diseases in human history, malaria now claims over 600,000 lives a year. Our mission is to investigate the production of affordable antimalarial drugs by the means of synthetic biology. We are working with artemisinic acid producing E.coli cells obtained from Amyris, with the support of Zagaya, and operating via our innovative metabolic pathway. We have constructed BioBrick components of the system, which should allow for easier research and development in the future. | One of the deadliest diseases in human history, malaria now claims over 600,000 lives a year. Our mission is to investigate the production of affordable antimalarial drugs by the means of synthetic biology. We are working with artemisinic acid producing E.coli cells obtained from Amyris, with the support of Zagaya, and operating via our innovative metabolic pathway. We have constructed BioBrick components of the system, which should allow for easier research and development in the future. | ||
</div> | </div> | ||
Revision as of 12:58, 6 October 2015
E.artemisia
Combating Malaria with Synthetic Biology
One of the deadliest diseases in human history, malaria now claims over 600,000 lives a year. Our mission is to investigate the production of affordable antimalarial drugs by the means of synthetic biology. We are working with artemisinic acid producing E.coli cells obtained from Amyris, with the support of Zagaya, and operating via our innovative metabolic pathway. We have constructed BioBrick components of the system, which should allow for easier research and development in the future.
